Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Transact Technologies (TACT) Research & Development (2016 - 2025)

Transact Technologies (TACT) has disclosed Research & Development for 16 consecutive years, with $1.7 million as the latest value for Q4 2025.

  • Quarterly Research & Development rose 5.58% to $1.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.7 million through Dec 2025, down 4.29% year-over-year, with the annual reading at $6.7 million for FY2025, 4.29% down from the prior year.
  • Research & Development hit $1.7 million in Q4 2025 for Transact Technologies, up from $1.7 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $2.5 million in Q3 2023 to a low of $1.6 million in Q4 2024.
  • Historically, Research & Development has averaged $2.0 million across 5 years, with a median of $1.9 million in 2021.
  • Biggest five-year swings in Research & Development: soared 32.53% in 2021 and later plummeted 34.64% in 2024.
  • Year by year, Research & Development stood at $2.0 million in 2021, then grew by 8.43% to $2.2 million in 2022, then dropped by 0.05% to $2.2 million in 2023, then dropped by 26.12% to $1.6 million in 2024, then grew by 5.58% to $1.7 million in 2025.
  • Business Quant data shows Research & Development for TACT at $1.7 million in Q4 2025, $1.7 million in Q3 2025, and $1.7 million in Q2 2025.